MedPath

CUREZMA PHARMA OPERATIONS PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

12

TGA:12

Drug Approvals

Curezma Junior ECZEMA ITCH Relief Anti-Flare Oil (449594)

Product Name
Curezma Junior ECZEMA ITCH Relief Anti-Flare Oil
Approval Date
May 24, 2024
TGA

Curezma Junior ECZEMA Gentle Head to Toe Wash (449595)

Product Name
Curezma Junior ECZEMA Gentle Head to Toe Wash
Approval Date
May 24, 2024
TGA

Curezma Plus Advanced ECZEMA Healing Serum (449593)

Product Name
Curezma Plus Advanced ECZEMA Healing Serum
Approval Date
May 24, 2024
TGA

Curezma Junior ECZEMA Soothing Sensitive Lotion (449059)

Product Name
Curezma Junior ECZEMA Soothing Sensitive Lotion
Approval Date
May 20, 2024
TGA

Curezma ECZEMA Soothing Sensitive Lotion (449058)

Product Name
Curezma ECZEMA Soothing Sensitive Lotion
Approval Date
May 20, 2024
TGA

Curezma Junior ECZEMA Barrier Repair Serum (448932)

Product Name
Curezma Junior ECZEMA Barrier Repair Serum
Approval Date
May 17, 2024
TGA

Curezma ECZEMA ITCH Relief Anti-Flare Oil (448931)

Product Name
Curezma ECZEMA ITCH Relief Anti-Flare Oil
Approval Date
May 17, 2024
TGA

Curezma ECZEMA Barrier Repair Serum (448930)

Product Name
Curezma ECZEMA Barrier Repair Serum
Approval Date
May 17, 2024
TGA

Curezma ECZEMA Gentle Wash (448933)

Product Name
Curezma ECZEMA Gentle Wash
Approval Date
May 17, 2024
TGA

Curezma Junior Intensive Ointment (425872)

Product Name
Curezma Junior Intensive Ointment
Approval Date
Oct 17, 2023
TGA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.